Loading
Latest filing published 09 Jul 2026 for Tonix Pharmaceuticals Holding Corp., €14k.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
This profile gathers the share dealings of Bradley Saenger in Tonix Pharmaceuticals Holding Corp. We count 4 filings; the first trade dates from 21 June 2016 and the latest from 30 June 2026.
No open-market sale appears; the market trades are 2 purchases worth €4,619. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The latest filing, published on 9 July 2026, reports a transaction of €14k in Tonix Pharmaceuticals Holding Corp. The last insider purchase was made public on 14 June 2018, 3,053 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 5 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations